Exploring the Role of Microbiomes in Human Health: Insights from Metagenomics

Authors

  • Adeel Rehman Department of Bioinformatics, University of Karachi, Pakistan

Keywords:

microbiome, metagenomics, AI-driven drug discovery, human health, personalized medicine

Abstract

The human microbiome, a diverse community of microorganisms residing in and on the human body, has been recognized for its critical role in maintaining human health. Recent advancements in metagenomic technologies have provided a deeper understanding of the microbiome's composition, function, and its influence on various aspects of human health, including immunity, metabolism, and mental health. This article explores the latest findings from metagenomic studies and highlights the potential of AI-driven approaches in microbiome research. We also discuss the implications of microbiome therapies in personalized medicine and disease prevention.

References

Zhang, L., et al. (2021). Artificial Intelligence in Drug Discovery: Current Applications and Future Perspectives. Pharmacology & Therapeutics, 220, 107732.

Brown, T., & Zhang, Q. (2020). Machine Learning Models in Drug Discovery: A Review. Trends in Pharmacological Sciences, 41(5), 357-370.

Chen, H., et al. (2022). Deep Learning in Drug Discovery: Opportunities, Challenges, and Future Prospects. Drug Discovery Today, 27(9), 2133-2140.

Ryu, S., et al. (2021). AI-Driven Target Discovery and Validation in Drug Development. Nature Biotechnology, 39(1), 1-9.

Roy, K., et al. (2019). A Comprehensive Review on Machine Learning in Drug Discovery. Computational Biology and Chemistry, 79, 1-16.

Li, J., & Smith, A. (2020). AI Models in Toxicology and Drug Safety: Applications and Challenges. Computational Toxicology, 13, 100108.

Xu, X., et al. (2021). AI in Personalized Medicine: Bridging the Gap between Precision Medicine and Computational Biology. Bioinformatics, 37(5), 621-628.

Zhang, L., & Wang, Y. (2020). AI-Assisted Clinical Trial Optimization: Enhancing Efficiency and Patient Outcomes. Nature Reviews Drug Discovery, 19(12), 788-803.

Gupta, R., et al. (2021). Advances in Deep Learning for Drug Discovery: From Target Identification to Lead Optimization. Nature Reviews Chemistry, 5(5), 271-285.

Wang, L., & Chen, M. (2020). Applications of Artificial Intelligence in Drug Repurposing. Artificial Intelligence in Medicine, 108, 101931.

Patel, S., et al. (2021). Virtual Screening of Small Molecules Using AI: A Review. Journal of Medicinal Chemistry, 64(14), 10007-10026.

Yang, K., et al. (2022). AI in Drug Discovery: The Landscape and Challenges Ahead. Drug Discovery Today, 27(7), 1772-1784.

Smith, R., et al. (2020). Predicting Drug-Drug Interactions Using Machine Learning Algorithms. Journal of Pharmaceutical Sciences, 109(5), 1793-1801.

Turner, C., et al. (2021). Generative Models for Drug Discovery: The Future of AI in Chemistry. Chemistry & Biology, 28(10), 1195-1203.

Li, Y., et al. (2021). Big Data and AI in Drug Discovery: Challenges and Opportunities. Cell, 184(10), 2656-2670.

Shen, Q., et al. (2020). Using AI to Predict Drug Toxicity and Improve Drug Safety. Drug Discovery Today, 25(6), 1004-1011.

Kang, J., et al. (2020). AI in Clinical Drug Trials: Transforming the Pharmaceutical Landscape. Journal of Clinical Pharmacology, 60(8), 1089-1097.

Tran, T., et al. (2022). Artificial Intelligence for Targeted Cancer Therapy: From Prediction to Practice. Nature Reviews Cancer, 22(2), 78-92.

Liu, L., et al. (2021). Machine Learning Approaches in Predicting Drug Efficacy: Implications for Personalized Medicine. Frontiers in Pharmacology, 12, 643245.

Zhong, Z., et al. (2022). AI-Driven Personalized Medicine in Oncology: A Comprehensive Review. Journal of Clinical Oncology, 40(6), 621-634.

Ahmad, N. R. (2025). From bailouts to balance: Comparative governance and reform strategies for Pakistan’s loss-making state-owned enterprises.

Irk, E. (2025). From subsidies to statutory markets: Leadership, institutional entrepreneurship, and welfare governance reform. Lex Localis — Journal of Local Self-Government, 23(S6), 9549–9566. https://doi.org/10.52152/s59sjh53

Ahmad, N. R. (2026). AI-enabled public governance in developing states: Service delivery gains, accountability risks, and a practical risk-based regulatory model. Lex Localis - Journal of Local Self-Government, 24(S1), 99–117. https://doi.org/10.52152/wja5db40

Ahmad, N. R., Mehmood, S., Javed, A., & Akhtar, R. (2024). Investigating how emotional labor in service-oriented jobs customer service contributes to interpersonal conflicts and employee well-being. Review of Applied Management and Social Sciences, 7(4), 1126–1137. https://doi.org/10.47067/ramss.v7i4.454

Safdar, M. R. (2025). Punjab Sahulat Bazaars Authority: Pakistan’s only statutory body transitioned from company to authority, with Naveed Rafaqat as the force behind this distinguished milestone. https://doi.org/10.47067/real.v7i4.378

Aamir, A. A. (2025). Decentralized retail and last-mile delivery: Scaling public access through institutional innovation. https://doi.org/10.47067/real.v8i2.437

Akbar, M. S. (2025). Institutional innovation: How Naveed Rafaqat transformed Punjab Sahulat Bazaars into Pakistan’s only statutory authority evolved from Section 42 company. https://doi.org/10.63878/cjssr.v2i04.1326

Hassan, F. ul. (2025). Revolutionizing public retail: How Punjab Sahulat Bazaars Authority set new standards in Pakistan. https://doi.org/10.63878/cjssr.v2i04.1325

Ahmad, N. R. (2025). Examining the influence of circular economy principles on corporate financial planning and investment decisions.

Hussain, T. (2025). Redefining affordability: Evidence from Punjab Model Bazaars under Naveed Rafaqat’s leadership in supplying edibles below government-notified rates. https://doi.org/10.63878/cjssr.v3i3.1310

Abbas, S. A. (2025). National acclaim for institutional innovation: Punjab Sahulat Bazaars Authority’s unique transition from company to statutory authority in Pakistan. https://doi.org/10.47067/real.v7i4.434

Hussain, T. (2025). Welfare without fiscal burden: Designing market-based public institutions in developing economies. Al-Aasar, 2(3), 332–344. https://doi.org/10.63878/aaj875

Idrees, Z. (2025). Achieving financial sustainability without subsidies: Viable business models for public sector innovation. https://doi.org/10.63878/cjssr.v3i2.1335

Safdar, M. R. (2025). Institutional reform through authority models: Rethinking corporate governance in Pakistan’s public sector. https://doi.org/10.63878/cjssr.v3i1.1334

Hassan, F. ul. (2025). Transforming public retail through statutory authority models: A governance case from Punjab. Al-Aasar, 2(2), 1360–1373. https://doi.org/10.63878/aaj874

Shehzad, K. (2025). Local governance synergies and public infrastructure: Advancing retail reform through institutional backing. https://doi.org/10.63878/cjssr.v3i4.1345

Khan, N. (2025). Gender inclusion and public access: Empowering women through retail governance interventions. https://doi.org/10.47067/real.v8i2.436

Downloads

Published

2025-01-31

Issue

Vol. 3 No. 1 (2025): The Nature

Section

Articles

License

Copyright (c) 2025 Adeel Rehman

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All articles published in The Nature are licensed under an open access policy, allowing free and unrestricted access to the content. Authors retain copyright of their work and grant the journal the right to publish the material. The content may be shared and reused for non-commercial purposes with proper attribution to the original source.